Anne-Francoise Allain

Title: The Innovative Contributions of Anne-Francoise Allain

Introduction

Anne-Francoise Allain is a notable inventor based in Saint-Lambert de Lauzon, Canada. She has made significant contributions to the field of biotechnology, particularly in the area of antihypertensive peptides derived from whey proteins. Her work has implications for both human health and the well-being of domestic pets.

Latest Patents

Anne-Francoise Allain holds a patent for the "Enzymatic treatment of whey proteins for the production of antihypertensive peptides and the resulting products." This innovative patent describes the preparation of enzymatic digests of whey protein concentrates using various proteases. The research highlights the highest ACE-inhibitory activity obtained with the purified peptide β-1g (f142–148) through chemical synthesis, demonstrating an IC value of 0.04 mg powder/ml. The hydrolysates derived from BiPRO™ whey protein isolate and β-1g exhibited higher antihypertensive activities compared to other tested hydrolysates. The recovered hydrolysate has potential applications in treating hypertension in mammals, including humans and domestic pets such as dogs and cats.

Career Highlights

Anne-Francoise Allain is currently employed at Davisco Foods International, Inc., where she continues to advance her research in the field of food science and biotechnology. Her work has garnered attention for its innovative approach to health-related applications of whey proteins.

Collaborations

Some of her notable coworkers include Martin E. Davis and Anand Rao, who have contributed to her research endeavors and collaborative projects.

Conclusion

Anne-Francoise Allain's innovative work in the enzymatic treatment of whey proteins showcases her commitment to advancing health solutions through biotechnology. Her contributions have the potential to impact both human and animal health positively.